FDA approves Pixclara, the first FDA-approved FET-PET imaging drug for glioma
The FDA has approved Pixclara®, the first FDA-approved FET-PET imaging drug for glioma. Here’s what the approval may mean for patients and care partners.
We collect real-world data to expose gaps in care, drive systemic change, and improve quality of life for everyone affected by glioblastoma.
We raise awareness about glioblastoma and advocate for better care for everyone living with GBM today.
Our GBM Bill of Rights guides GBM patients and care partners about getting a second opinion, seeing specialists, tumor testing, and more.
OurBrainBank UK #UseYourBrains! campaign demands action to support glioblastoma.
OurBrainBank turns patient and caregiver voices into actionable research that improves GBM care.
Powered by Patients.
Supported by You.
Our work is made possible by individuals and partners committed to transforming GBM care.

The FDA has approved Pixclara®, the first FDA-approved FET-PET imaging drug for glioma. Here’s what the approval may mean for patients and care partners.
My mother-in-law Karla told me she had a brain tumor before she told my wife Michelle. Karla and Michelle were inseparable. Karla had Michelle at just 18, so in many ways, they grew up together. Michelle shared everything with her mom because Karla was her best friend…
Help us spread the word on Glioblastoma Awareness Day: July 15, 2026. Tell your GBM story.
Advance care planning helps ensure your values, goals, and wishes guide your future medical care—not just during a medical crisis, but throughout the glioblastoma journey.
Join us for the next GBM Voices educational webinar with neuro-oncology expert Jennifer N. Serventi, MS, PA-C.
Many people hear the words palliative care and immediately think hospice or end-of-life care. In reality, palliative care can play an important role throughout the brain cancer journey by helping patients and caregivers manage symptoms, improve quality of life, navigate difficult decisions, and access the support they need.